{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:55:07Z","timestamp":1791201307528,"version":"4.2.0"},"reference-count":26,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Objective: We aim to characterize patients undergoing pericardiocentesis for clinically significant pericardial effusion and explore differences in inflammation-based biomarkers according to malignancy status and one-year outcome. Methods: We retrospectively evaluated 113 consecutive patients who underwent pericardiocentesis between January 2021 and January 2026. Clinical, laboratory, pericardial fluid, cytopathological, recurrence, and mortality data were analyzed. NLR, PLR, SII, SIRI, and PIV were assessed as secondary exploratory biomarkers. Results: Malignancy-associated pericardial effusion was present in 36 patients (31.9%), while 77 (68.1%) had non-malignant effusion. The malignancy-associated group had more frequent dyspnea (77.8% vs. 55.8%; p = 0.025), effusion &gt;15 mm (80.6% vs. 58.4%; p = 0.021), hemorrhagic fluid (75.0% vs. 54.5%; p = 0.038), and recurrence (38.9% vs. 20.8%; p = 0.042). Malignant cells were identified in pericardial fluid cytology in 15\/36 patients (41.7%). One-year mortality was 22.2% versus 13.0% (p = 0.211). NLR, PLR, SII, SIRI, and PIV did not differ significantly according to malignancy status or one-year mortality; NLR, PLR, and SIRI were higher in the exploratory lung cancer subgroup. Conclusions: Malignancy-associated pericardial effusion showed distinct clinical and fluid characteristics. No statistically significant associations were detected between the evaluated inflammation-based biomarkers and malignancy status or one-year mortality; however, the exploratory design and limited number of outcome events warrant cautious interpretation.<\/jats:p>","DOI":"10.3390\/jcm15197679","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:57:46Z","timestamp":1791197866000},"page":"7679","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Outcomes of Patients Undergoing Pericardiocentesis for Pericardial Effusion: A Single-Center Experience with Exploratory Inflammatory Biomarker Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5508-9474","authenticated-orcid":false,"given":"Zeynep","family":"Yapan Emren","sequence":"first","affiliation":[{"name":"Department of Cardiology, Bak\u0131r\u00e7ay University \u00c7i\u011fli Training and Research Hospital, Izmir 35620, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4704-7415","authenticated-orcid":false,"given":"Gamze","family":"Erk\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[{"name":"Department of Pathology, Bak\u0131r\u00e7ay University \u00c7i\u011fli Training and Research Hospital, Izmir 35620, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,4]]},"reference":[{"key":"ref_1","first-page":"1121","article-title":"Chronic pericardial effusion: Causes and management","volume":"39","author":"Lazaros","year":"2023","journal-title":"Can. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases","volume":"36","author":"Adler","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11886-019-1225-6","article-title":"Cancer treatment-associated pericardial disease: Epidemiology, clinical presentation, diagnosis, and management","volume":"21","author":"Ala","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.14797\/mdcvj.1761","article-title":"Malignant pericardial effusion: Heart-breaking tumors","volume":"22","year":"2026","journal-title":"Methodist DeBakey Cardiovasc. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.cjco.2024.05.003","article-title":"Malignant pericardial effusion: A systematic review","volume":"6","author":"Mudra","year":"2024","journal-title":"CJC Open"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/0284186X.2018.1546057","article-title":"The prognostic role of inflammation-scores on overall survival in lung cancer patients","volume":"58","author":"Meldgaard","year":"2019","journal-title":"Acta Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Winther-Larsen, A., Aggerholm-Pedersen, N., and Sandfeld-Paulsen, B. (2022). Inflammation-scores as prognostic markers of overall survival in lung cancer: A register-based study of 6210 Danish lung cancer patients. BMC Cancer, 22.","DOI":"10.1186\/s12885-021-09108-5"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.30057","article-title":"A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy","volume":"122","author":"Qi","year":"2016","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41416-020-0894-7","article-title":"The pan-immune-inflammation value is a new prognostic biomarker in metastatic colorectal cancer: Results from a pooled analysis of the Valentino and TRIBE first-line trials","volume":"123","author":"Guarini","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e13230","DOI":"10.1111\/eci.13230","article-title":"Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease","volume":"50","author":"Yang","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Guven, D.C., Sahin, T.K., Erul, E., Kilickap, S., Gambichler, T., and Aksoy, S. (2022). The association between the pan-immune-inflammation value and cancer prognosis: A systematic review and meta-analysis. Cancers, 14.","DOI":"10.3390\/cancers14112675"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.18663\/tjcl.1403742","article-title":"Mide kanseri n\u00fcks\u00fc ve mortalitesinin bir belirteci olarak pan-imm\u00fcn inflamasyon de\u011feri","volume":"15","author":"Kartal","year":"2024","journal-title":"Turk. J. Clin. Lab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e13872","DOI":"10.1111\/eci.13872","article-title":"Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction","volume":"53","author":"Murat","year":"2023","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.2147\/JIR.S421491","article-title":"Association of systemic inflammatory response index and pan-immune-inflammation-value with long-term adverse cardiovascular events in ST-segment elevation myocardial infarction patients after primary percutaneous coronary intervention","volume":"16","author":"Liu","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC Guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Collini","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/1097-0142(19951015)76:8<1377::AID-CNCR2820760813>3.0.CO;2-M","article-title":"Malignancy-related pericardial effusion: 127 cases from the Roswell Park Cancer Institute","volume":"76","author":"Wilkes","year":"1995","journal-title":"Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bartoli, L., Angeli, F., Stefanizzi, A., Fabrizio, M., Paolisso, P., Bergamaschi, L., Broccoli, A., Zinzani, P.L., Gali\u00e8, N., and Rucci, P. (2022). Genetics and clinical phenotype of Erdheim-Chester disease: A case report of constrictive pericarditis and a systematic review of the literature. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.876294"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: Triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Trimarchi, G., Pizzino, F., Lilli, A., De Caterina, A.R., Esposito, A., Dalmiani, S., Mazzone, A., Di Bella, G., Berti, S., and Paradossi, U. (2024). Advanced Lung Cancer Inflammation Index as Predictor of All-Cause Mortality in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. J. Clin. Med., 13.","DOI":"10.3390\/jcm13206059"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kuang, T., Qiu, Z., Wang, K., Zhang, L., Dong, K., and Wang, W. (2024). Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1326083"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chiruvella, V., Ullah, A., Elhelf, I., Patel, N., and Karim, N.A. (2022). Would the addition of immunotherapy impact the prognosis of patients with malignancy-associated pericardial effusion?. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.871132"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7679\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:11:27Z","timestamp":1791198687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,4]]},"references-count":26,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197679"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197679","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,4]]}}}